Navigation Links
XBiotech Expands Portfolio to Include Biosimilars
Date:2/26/2013

f branded biologics, such as Amgen, and diverse entrants, such as Samsung, into the biosimilar development. However, with the large number of developers there remains considerable uncertainty about how market share is going to be divided, once a number of competing products hit the market.

Simard added that "In the biosimilar space cost competitiveness is going to be crucial to the success of these products. Market share is going to be driven by the ability to provide these products to the end user at lower costs than the competitor's. Developers capable of dramatically reducing cost of goods and establishing innovative distribution strategies will ultimately be able to dominate the biosimilar market. We believe XBiotech is well positioned to take advantage of this opportunity."

About XBiotech
XBiotech is pioneering breakthrough therapies that improve the safety and efficacy of antibody therapeutics. The Company's lead product candidate inhibits chronic sterile inflammation by targeting IL-1α, a master regulator of inflammation. The clinical development program addresses tremendous unmet medical need in multiple disease indications including, acne, psoriasis, cachexia, cancer, type 2 diabetes and cardiovascular disease. XBiotech is also revolutionizing scalable, flexible manufacturing systems for the production of biological therapies.  Using minimal infrastructure and disposable bioreactor technology – to dramatically reduce capital requirements, operating complexity, and lead times - the Company has established a compelling commercialization path for therapeutic antibodies.  For more information on how XBiotech is advancing human monoclonal antibody therapy please visit www.xbiotech.com.

Contact: 
Investors: 
Erika Geimonen
XBiotech
info@xbiotech.com
512.386.2906
Media:
Aaron
'/>"/>

SOURCE XBiotech
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. XBiotech Announces Positive Phase II Clinical Trial Results for Lead Candidate MABp1 in Acne Vulgaris
2. RF Technologies expands product offering with RTLS
3. Life Technologies Acquires BAC BV, Expands Capabilities in Bioprocessing
4. Superlift Expands Line of Stainless Steel Powered Pallet Trucks
5. UMBC Expands Offerings at The Universities at Shady Grove with Biotechnology Graduate Program
6. 1DegreeBio Expands its Product Review Platform Across Life Sciences
7. Genuine Bio-Fuel Inc. Expands Operations to Puerto Rico
8. Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
9. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
10. Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
11. Why Texas is #1 in Business: Local BioTech Company Expands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... DUBLIN , Aug. 27, 2014 ... the "Global Enzyme for Pulp & Paper Industry ... The Global Enzyme for Pulp & Paper Industry ... the current state of the global enzyme for pulp ... basic overview of the industry including definitions, classifications, applications ...
(Date:8/27/2014)... BIOEQUA, an innovative line of skin care ... handheld spray, has made its EQUA ESSENTIAL line available ... brand began with an unexpected discovery in an emergency ... that the application of nanospray technology allowed for liquid ... to skin's basal layer. This resulted in immediate absorption ...
(Date:8/27/2014)... 27, 2014 Budding Biomedical Scientists ... University School participated in the Scientific Enrichment ... University’s School of Medicine . , ... unparalleled professional experience in the sciences and brings ... faculty and students for both academic and career ...
(Date:8/26/2014)... The 20 ambassadors representing the ALS Therapy Development ... following statement on Facebook today regarding the global Ice ... specifically for ALS research: , “Who would have thought ... raise all this awareness and funding toward ALS research! ... of the entire ALS community, would like to express ...
Breaking Biology Technology:Global Enzyme for Pulp & Paper Industry Report 2014 2BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2Students at Cleveland's University School Conduct Biomedical Research at Case Western Reserve University’s School of Medicine 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 3ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 4
... 24, 2011 Champions Biotechnology, Inc. (OTC: CSBR) ... collaboration agreement with Cephalon, Inc. in which Champions ... proprietary chemical compounds, CEP-32496, an inhibitor of mutant ... provided by Cephalon to determine the activity or ...
... ValGenesis, Inc., an industry-leading provider of Validation ... availability of its industry-proven solution as an On-Demand ... MUSA,s Validated Cloud. ValGenesis On-Demand provides ... via the Internet through MUSA,s Validated Cloud on ...
... Medicine, Inc. (RBM), a leading provider of innovative biomarker ... ® , a powerful tool developed at the direction ... Through quantitative measurement of 101 cancer-related proteins, OncologyMAP ... biological pathways that could hold the key to understanding ...
Cached Biology Technology:Champions Announces Technology Collaboration Utilizing Champions' Tumorgraft™ Technology Platform for Oncology Drug Development 2Champions Announces Technology Collaboration Utilizing Champions' Tumorgraft™ Technology Platform for Oncology Drug Development 3Announcing ValGenesis On-Demand SaaS Solution 2Announcing ValGenesis On-Demand SaaS Solution 3Rules-Based Medicine Launches OncologyMAP® to Advance Cancer-Related Drug and Diagnostic Development 2
(Date:8/27/2014)... that exists as five strains, none of which have ... the Sudan ebolavirus (SUDV). Although not the strain currently ... as recently as 2012. In a new study appearing ... now report a possible therapy that could someday help ... Sidhu, Jonathan Lai and colleagues explain that about 50-90 ...
(Date:8/27/2014)... the long-standing belief that a deficiency in serotonin ... central role in depression. In the journal ACS ... ability to make serotonin in their brains (and thus ... show depression-like symptoms. , Donald Kuhn and colleagues ... Wayne State University School of Medicine note that depression ...
(Date:8/27/2014)... each year in U.S. waters and become what are ... crabs, and other species such as turtles. These traps ... who depend on the resources--losses that are largely preventable, ... report, published in the Marine Pollution Bulletin , ... derelict fish trap problem, and so-called "ghost fishing," nationally, ...
Breaking Biology News(10 mins):Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2New study throws into question long-held belief about depression 2NOAA's Marine Debris Program reports on the national issue of derelict fishing traps 2
... as current directions and water temperature play a huge ... as they move from rivers and hit ocean waters ... findings inform restoration policies and practices focused on boosting ... findings, from ecologists at the Department of Energy,s Pacific ...
... The National Science Foundation (NSF), in cooperation with ... round of awards under a program that supports ... predictability, resiliency and sustainability of the natural and ... governance of the Arctic. Six projects ...
... international team of researchers says in a new paper ... realm more practical applications for dealing with the ... already exists as does much of the organizational structure, ... ranging from declining snowpack, to severe storms, to sea ...
Cached Biology News:Tracking young salmon's first moves in the ocean 2Tracking young salmon's first moves in the ocean 3Tracking young salmon's first moves in the ocean 4NSF, with interagency and international partners, makes first round of grants to understand Arctic sustainability 2NSF, with interagency and international partners, makes first round of grants to understand Arctic sustainability 3NSF, with interagency and international partners, makes first round of grants to understand Arctic sustainability 4NSF, with interagency and international partners, makes first round of grants to understand Arctic sustainability 5NSF, with interagency and international partners, makes first round of grants to understand Arctic sustainability 6Researchers advocate for climate adaptation science 2Researchers advocate for climate adaptation science 3
Reported to support murine B lymphocytes, hematopoietic tissue from bone marrow, B cells stimulated with lipopolysaccharide, T lymphocytes, and a variety of hybrid cells....
... Applied Biosystems and MDS Sciex ... System, a high performance hybrid triple ... the drug discovery, drug development or ... (LIT) Technology from the leaders in ...
... Many modifications of Eagle's ... the original formulation. The most ... Modified Eagle's,Medium. DME is a ... Eagle [MEM] that contains a ...
... isotonic, balanced salt solution. It is routinely used ... of whole blood at refrigerator temperatures for approximately ... blood is collected into a container of this ... is placed in a refrigerator at 2-8 C ...
Biology Products: